1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsChemical & Biological Defense (CBD) SBIR Program is sponsored by Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). The Chemical & Biological Defense (CBD) SBIR program supports innovative small businesses developing dual-use technologies that strengthen biodefense, force protection, medical readiness, and public-health resilience.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
SBD SBIR | Chemical & Biological Defense Innovation Funding Chemical & Biological Defense (CBD) SBIR: Advancing Biosurveillance , Diagnostics, and Protective Readiness for National Security The Chemical & Biological Defense (CBD) SBIR program , overseen by the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) , supports innovative small businesses developing dual-use technologies that strengthen biodefense, force protection, medical readiness, and public-health resilience.
CBD SBIR topics are closely aligned with CBRN mission gaps and may be informed by the operational needs of Defense Threat Reduction Agency (DTRA), Medical CBRN Defense Consortium (MCDC), and Service-based medical enterprise programs .
Rather than incremental R&D, CBD SBIR emphasizes deployable biosurveillance , rapid diagnostics, environmental detection, chemical sensing, threat modeling, medical countermeasure platforms, PPE improvement, and hazard-response technologies .
Priority domains include : point-of-care diagnostics, syndromic surveillance algorithms, early-warning biosensors, rapid sample preparation tools, next-generation decontamination chemistries, aerosol or waterborne pathogen detection, field-deployable sequencing, infectious-disease analytics, novel PPE materials, force-protection medical monitoring, and decision-support software for bio-event assessment or environmental monitoring .
Many topics emphasize ruggedization, low-power operation, manufacturability, cyber-secure data handling, and integration with defense logistics or command-and-control networks .
Phase I CBD SBIR awards typically range from $150,000 to $250,000 and support feasibility studies—such as sample characterization, assay concept validation, algorithm modeling, benchtop experimentation, computational biosurveillance proofs, or system-level architecture design.
Phase II awards generally range from $1,000,000 to $1,700,000 and focus on prototype development, biological characterization, manufacturability assessment, AI-based surveillance integration, field trials at government test sites, or regulatory alignment for medical countermeasure applications. Direct-to-Phase-II options may also exist for companies with validated prototype performance or commercial proof.
CBD SBIR performers often require deep technical credibility in biology, chemistry, chemical analytics, materials science, environmental sensing, microelectronics, biomedical engineering, or computational biosurveillance .
However, the CBD SBIR portfolio is highly open to innovative nontraditional firms , particularly those developing dual-use sensing, autonomous analytics, ruggedized IoT systems, mobile diagnostics, or secure cloud tools for laboratory or field testing.
Eligibility mirrors standard SBIR rules: U.S.-owned for-profit small businesses under 500 employees , with at least 50% of work performed by the small business and the Principal Investigator primarily employed by the business .
Universities, hospitals, medical labs, and federally funded research organizations may subcontract to provide BSL-compliant laboratory capacity, algorithmic modeling, regulatory insight, assay development, or test-range support. Projects involving select agents, export-controlled biological materials, or hazardous CBRN substances must comply with BSL requirements, safety standards, and DoD ethics/regulatory frameworks.
CBD SBIR encourages early user engagement with CBRN program offices, government laboratories, or Service test centers to improve transition potential. The most competitive proposals emphasize mission relevance, ruggedization, manufacturability, deployment workflow fit, commercial viability, and dual-use scalability across healthcare, environmental monitoring, food safety, critical infrastructure protection, or emergency management.
JPEO-CBRND: https://www. jpeocbrnd. osd.
mil DoD SBIR Portal: https://www. dodsbirsttr. mil ScienceDocs assists CBD SBIR applicants with technical proposal development, biosurveillance strategy writing, regulatory planning, prototype framing, and commercialization narratives tailored to defense and civilian deployment.
If your small business is preparing a CBD SBIR submission or needs expert proposal development assistance , please begin the conversation at: https://www. sciencedocs. com/quotes Find grants, services, and resources across our site.
According to the current listing, eligibility includes: U. S. -owned for-profit small businesses under 500 employees, with at least 50% of work performed by the small business and the Principal Investigator primarily employed by the business. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: $150,000 to $250,000; Phase II: $1,000,000 to $1,700,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Chemical & Biological Defense (CBD) SBIR Program is funded by Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DARPA's Defense Sciences Office and Biological Technologies Office pre-released four SBIR XL topics on June 3 with proposals open June 24 and due July 22. Read the four as a single coordinated bet on the deployed soldier — sensing, recovery, power, and pathogen defense — and the strategy for filing across the quartet becomes clear.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article